165 related articles for article (PubMed ID: 7535430)
21. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
Waddick KG; Uckun FM
Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
[TBL] [Abstract][Full Text] [Related]
22. T-cell depletion and allogeneic bone marrow transplantation.
O'Reilly RJ
Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
[No Abstract] [Full Text] [Related]
23. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow.
Hardwick A; Law P; Mansour V; Kulcinski D; Ishizawa L; Gee A
Prog Clin Biol Res; 1992; 377():583-9. PubMed ID: 1279728
[No Abstract] [Full Text] [Related]
24. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia.
Wunder E; Sovalat H; Liang H; Becker M; Henon P
Prog Clin Biol Res; 1994; 389():345-50. PubMed ID: 7535441
[No Abstract] [Full Text] [Related]
25. Transplantation of stem cells enriched by immunoadsorption.
Berenson RJ; Bensinger WI; Kalamasz DF; Heimfeld S; Goffe RA; Berninger RW; Peterson DR; Thompson P; Strong DM
Prog Clin Biol Res; 1992; 377():449-57; discussion 458-9. PubMed ID: 1279714
[No Abstract] [Full Text] [Related]
26. The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.
Nagler A; Morecki S; Slavin S
Mol Biotechnol; 1999 Apr; 11(2):181-94. PubMed ID: 10464772
[TBL] [Abstract][Full Text] [Related]
27. Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia.
Vervoordeldonk SF; van den Berg H; von dem Borne AE; van Leeuwen EF; Slaper-Cortenbach IC
J Hematother; 1997 Oct; 6(5):495-500. PubMed ID: 9368186
[TBL] [Abstract][Full Text] [Related]
28. Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads.
Kvalheim G; Jakobsen E; Holte H; Beiske K; Langholm R; Høiby A; Wang MY; Funderund S; Fodstad O; Smeland E
Prog Clin Biol Res; 1994; 389():133-8. PubMed ID: 7700895
[No Abstract] [Full Text] [Related]
29. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
30. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
Blystad A; Kvalheim G; Torlakovic E; Holte H; Jacobsen E; Beiske K; Vâlerhaugen H; Lenschow E; Kvaloy S
Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
[TBL] [Abstract][Full Text] [Related]
31. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells.
Purdy MH; Shpall EJ
Med Oncol; 1994; 11(2):47-51. PubMed ID: 7531586
[No Abstract] [Full Text] [Related]
32. Peanut agglutinin purging and magnetic microspheres.
Rhodes EG; Baker PK; Duguid JK; Cawley JC
Prog Clin Biol Res; 1992; 377():139-46. PubMed ID: 1438410
[No Abstract] [Full Text] [Related]
33. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts.
Sieber F; Gaffney DK; Yamazaki T; Qiu K
Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897
[No Abstract] [Full Text] [Related]
34. Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantation.
Pineiro L; Fay J; Collins R; Herzig G
Prog Clin Biol Res; 1994; 389():17-21. PubMed ID: 7700899
[No Abstract] [Full Text] [Related]
35. Purging tumor cells from bone marrow or peripheral blood using avidin-biotin immunoadsorption.
Stray KM; Corpuz S; Kalamasz D; Colter M; Berenson R; Heimfeld S
Prog Clin Biol Res; 1994; 389():97-103. PubMed ID: 7535467
[No Abstract] [Full Text] [Related]
36. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.
Arcaini L; Orlandi E; Alessandrino EP; Iacona I; Brusamolino E; Bonfichi M; Bernasconi P; Calatroni S; Tenore A; Montanari F; Troletti D; Pascutto C; Regazzi M; Lazzarino M
Bone Marrow Transplant; 2004 Jul; 34(2):175-9. PubMed ID: 15170171
[TBL] [Abstract][Full Text] [Related]
37. Isolation of primitive hematopoietic stem cells.
Wagner JE
Semin Hematol; 1992 Apr; 29(2 Suppl 1):6-9. PubMed ID: 1377405
[No Abstract] [Full Text] [Related]
38. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
[No Abstract] [Full Text] [Related]
39. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
Macintyre EA
Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492
[No Abstract] [Full Text] [Related]
40. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Krüger W; Gruber M; Hennings S; Fehse N; Fehse B; Gutensohn K; Kröger N; Zander AR
Bone Marrow Transplant; 1998 Apr; 21(7):665-71. PubMed ID: 9578305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
